Janney Montgomery Scott
RGNX icon

Janney Montgomery Scott’s Regenxbio RGNX Stock Holding History

Janney Montgomery Scott’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56,029
Closed -$541K – 3003
2025
Q3 		$541K Sell
56,029
-1,564
-3% -$13.8K ﹤0.01% 2096
2025
Q2 		$473K Sell
57,593
-10,159
-15% -$85K ﹤0.01% 2050
2025
Q1 		$484K Buy
+67,752
New +$504K ﹤0.01% 2008
2024
Q4 		– Sell
-10,725
Closed -$113K – 2821
2024
Q3 		$113K Sell
10,725
-1,562
-13% -$19K ﹤0.01% 2575
2024
Q2 		$144K Sell
12,287
-2,124
-15% -$33.1K ﹤0.01% 2495
2024
Q1 		$304K Buy
+14,411
New +$256K ﹤0.01% 2335

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Janney Montgomery Scott's RGNX Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Regenxbio (RGNX) in Q4 2025, closing a stake of 56,029 shares — an estimated $541K sold.

Janney Montgomery Scott first reported a position in RGNX in Q1 2024 and held it in 6 quarters. The position peaked at $541K in Q3 2025. 174 funds tracked by Wall St. Rank hold RGNX as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Regenxbio position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 56,029 Regenxbio shares in Q4 2025, an estimated $541K.
  • Janney Montgomery Scott first reported a position in Regenxbio in Q1 2024 and held it in 6 quarters.
  • Janney Montgomery Scott's Regenxbio position peaked at $541K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.